Updates on the prevention of Respiratory Syncytial Virus (RSV) infection (33 min.)
$25.00
In this presentation, Dr. Jonathan Levin reviews the history and challenges for RSV vaccine development. Dr. Levin also discusses the evidence and indications for the maternal RSV vaccine; explains the evidence and indications for nirsevimab (anti-RSV mAb); and specifies the practical issues around implementation of nirsevimab in the NICU setting. This presentation was recorded at the Advances in Pediatric Health Care Conference on November 2, 2023.
Description
Jonathan Levin, MD, MBICo-Director, Chronic Pulmonary and Ventilator Program; Attending Physician, Divisions of Newborn Medicine and Pulmonary Medicine
Instructor of Pediatrics, Harvard Medical School
Learning Objectives:
At the conclusion of this educational program, learners will be able to:
- discuss the history and challenges of RSV vaccine development
- evaluate the evidence and indications for the maternal RSV vaccine
- evaluate the evidence and indications for nirsevimab (anti-RSV mAb)
- identify practical issues around implementation of nirsevimab in the NICU setting
Accreditation
In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician
Boston Children’s Hospital designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
MOC II
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn:
1 MOC points in the American Board of Pediatrics (ABP) Maintenance of Certification (MOC) program
Physician Assistant
Boston Children’s Hospital has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nurse
Boston Children’s Hospital designates this activity for 1.0 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Policy
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
Disclosure Statement
The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:
Jonathan Levin, MD: Site Investigator for RSVPeds therapeutic trial at BCH, Enanta
Additional information
| Credit Type | AAPA Category 1 (Physician Assistant), ABP MOC Part II (Pediatrician), AMA PRA Category 1 Credits™ (MD, DO, NP, PA), Contact Hours (Nurse, Nurse Practitioner) |
|---|---|
| Duration | |
| Format | |
| Topic | General Pediatrics, Infectious disease, Newborn Medicine, Pulmonary/Respiratory Disease |
| Expiration Date | |
| Release Date |
